Us Bancorp \De\ Bio N Tech Se Transaction History
Us Bancorp \De\
- $77.3 Billion
- Q3 2024
A detailed history of Us Bancorp \De\ transactions in Bio N Tech Se stock. As of the latest transaction made, Us Bancorp \De\ holds 4,678 shares of BNTX stock, worth $574,692. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,678
Previous 25,690
81.79%
Holding current value
$574,692
Previous $2.06 Million
73.11%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding BNTX
# of Institutions
356Shares Held
38.3MCall Options Held
2.45MPut Options Held
2.29M-
Baillie Gifford & CO8.31MShares$1.02 Billion0.75% of portfolio
-
Primecap Management CO Pasadena, CA4.52MShares$555 Million0.4% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.36MShares$536 Million2.05% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$233 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$222 Million0.88% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $29.8B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...